BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

BXPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

BXPHARMA 07-Nov-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 11, 2021 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.

BXPHARMA 24-Oct-2021

The Board of Directors has recommended 35% cash dividend for the year ended on June 30, 2021. Date of AGM: 23.12.2021, Time: 10:30 AM, Venue: Digital Platform. Record Date: 22.11.2021. The Company has also reported Consolidated EPS of Tk. 11.49, Consolidated NAV per share of Tk. 83.01 and Consolidated NOCFPS of Tk. 13.50 for the year ended on June 30, 2021 as against Tk. 7.88, Tk. 80.12 and Tk. 13.67 respectively for the same period of the previous year.

BXPHARMA 12-Oct-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 21, 2021 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

BXPHARMA 22-Apr-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Corporation has informed that a meeting of the Board of Directors will be held on April 29, 2021 at 2:30 PM to consider, among others, un-audited financial statements of the Corporation for the Third Quarter (Q3) period ended on March 31, 2021.

BXPHARMA 24-Jan-2021

The Company has informed that Board of Directors of the company in their meeting held on January 21, 2021 at 2.30 PM decided to enter into a binding commitment with Sanofi Group regarding the acquisition of a majority stake in Sanofi Bangladesh Limited for a base-price consideration of circa Pound 35.5 million, to be adjusted as set out below (the Proposed Transaction). The Proposed Transaction is subject to approval by the Bangladesh Bank and completing the Share Purchase Agreement. (Cont.1)

BXPHARMA 18-Jan-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 27, 2021 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.

BXPHARMA 04-Nov-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2020 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2020.

BXPHARMA 29-Oct-2020

The Board of Directors has recommended 15% cash and 10% stock dividend for the year ended on June 30, 2020. Date of AGM: 19.12.2020, Time: 10:30 AM, Venue: Digital Platform. Record Date: 25.11.2020. The Company has also reported Consolidated EPS of Tk. 8.67, Consolidated NAV per share of Tk. 80.12 and Consolidated NOCFPS of Tk. 13.67 for the year ended on June 30, 2020 as against Tk. 7.48, Tk. 72.96 and Tk. 7.30 respectively for the same period of the previous year.

BXPHARMA 21-Oct-2020

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2020 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2020.

BXPHARMA 17-Jun-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on June 22, 2020 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2020.

Previous Next page